These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 20195644

  • 1. Non-immunologic mechanisms of calcineurin inhibitors explain its antiproteinuric effects in genetic glomerulopathies.
    Bensman A, Niaudet P.
    Pediatr Nephrol; 2010 Jul; 25(7):1197-9. PubMed ID: 20195644
    [Abstract] [Full Text] [Related]

  • 2. Successful treatment of steroid-resistant nephrotic syndrome associated with WT1 mutations.
    Gellermann J, Stefanidis CJ, Mitsioni A, Querfeld U.
    Pediatr Nephrol; 2010 Jul; 25(7):1285-9. PubMed ID: 20191369
    [Abstract] [Full Text] [Related]

  • 3. Effect of cyclosporine therapy with low doses of corticosteroids on idiopathic nephrotic syndrome.
    Griveas I, Visvardis G, Papadopoulou D, Nakopolou L, Karanikas E, Gogos K, Stavianoudakis G.
    Artif Organs; 2010 Mar; 34(3):234-7. PubMed ID: 20447050
    [Abstract] [Full Text] [Related]

  • 4. Focal segmental glomerulosclerosis complicating solitary kidney.
    Oshiro Y, Umena S, Noda M.
    Clin Exp Nephrol; 2009 Feb; 13(1):81-4. PubMed ID: 18688570
    [Abstract] [Full Text] [Related]

  • 5. Cyclosporine A responsive congenital nephrotic syndrome with single heterozygous variants in NPHS1, NPHS2, and PLCE1.
    Eichinger A, Ponsel S, Bergmann C, Günthner R, Hoefele J, Amann K, Lange-Sperandio B.
    Pediatr Nephrol; 2018 Jul; 33(7):1269-1272. PubMed ID: 29663071
    [Abstract] [Full Text] [Related]

  • 6. Glomerular abundance of nephrin and podocin in experimental nephrotic syndrome: different effects of antiproteinuric therapies.
    Nakhoul F, Ramadan R, Khankin E, Yaccob A, Kositch Z, Lewin M, Assady S, Abassi Z.
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F880-90. PubMed ID: 15942045
    [Abstract] [Full Text] [Related]

  • 7. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
    Liu ID, Willis NS, Craig JC, Hodson EM.
    Cochrane Database Syst Rev; 2019 Nov 21; 2019(11):. PubMed ID: 31749142
    [Abstract] [Full Text] [Related]

  • 8. Nail-patella syndrome, infantile nephrotic syndrome: complete remission with antiproteinuric treatment.
    Soliman N.
    Nephrol Dial Transplant; 2009 Sep 21; 24(9):2951; author reply 2951-2. PubMed ID: 19541663
    [No Abstract] [Full Text] [Related]

  • 9. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
    Hodson EM, Wong SC, Willis NS, Craig JC.
    Cochrane Database Syst Rev; 2016 Oct 11; 10(10):CD003594. PubMed ID: 27726125
    [Abstract] [Full Text] [Related]

  • 10. Long-term treatment by ACE inhibitors and angiotensin receptor blockers in children with Alport syndrome.
    Zhang Y, Wang F, Ding J, Zhang H, Liu X, Wang S, Xiao H, Yao Y, Liu J, Zhong X, Guan N, Su B, Wu G, Yu L.
    Pediatr Nephrol; 2016 Jan 11; 31(1):67-72. PubMed ID: 26248473
    [Abstract] [Full Text] [Related]

  • 11. [The effect of cyclosporine A in steroid-dependent nephrotic syndrome in children].
    Wasilewska A, Zoch-Zwierz W, Tomaszewska B, Tenderenda E.
    Pol Merkur Lekarski; 2005 Feb 11; 18(104):168-72. PubMed ID: 17877123
    [Abstract] [Full Text] [Related]

  • 12. The podocyte as a target: cyclosporin A in the management of the nephrotic syndrome caused by WT1 mutations.
    Stefanidis CJ, Querfeld U.
    Eur J Pediatr; 2011 Nov 11; 170(11):1377-83. PubMed ID: 21298518
    [Abstract] [Full Text] [Related]

  • 13. [Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome].
    Working Group For National Survey On Status Of Diagnosis And Treatment Of Childhood Renal Diseases.
    Zhonghua Er Ke Za Zhi; 2014 Mar 11; 52(3):194-200. PubMed ID: 24824389
    [Abstract] [Full Text] [Related]

  • 14. Effect of cyclosporin A on proteinuria in the course of glomerulopathy associated with WT1 mutations.
    Wasilewska AM, Kuroczycka-Saniutycz E, Zoch-Zwierz W.
    Eur J Pediatr; 2011 Mar 11; 170(3):389-91. PubMed ID: 20848129
    [Abstract] [Full Text] [Related]

  • 15. Cyclosporine in Pediatric Nephrology.
    Arslansoyu Camlar S, Soylu A, Kavukçu S.
    Iran J Kidney Dis; 2018 Nov 11; 12(6):319-330. PubMed ID: 30595561
    [Abstract] [Full Text] [Related]

  • 16. [RAS blockade].
    Jin C, Ito S.
    Nihon Rinsho; 2004 Oct 11; 62(10):1880-4. PubMed ID: 15500134
    [Abstract] [Full Text] [Related]

  • 17. [Nephrotic syndrome refractory to conventional therapy].
    Ragazzoni E, Agliata S, Airoldi G, Fortina F, Sacco A, Schweiger K, Tommasini G, Cavagnino A.
    Minerva Urol Nefrol; 1999 Jun 11; 51(2):89-94. PubMed ID: 10429418
    [Abstract] [Full Text] [Related]

  • 18. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome.
    Alexopoulos E, Papagianni A, Tsamelashvili M, Leontsini M, Memmos D.
    Nephrol Dial Transplant; 2006 Nov 11; 21(11):3127-32. PubMed ID: 16968719
    [Abstract] [Full Text] [Related]

  • 19. Partial remission with cyclosporine A in a patient with nephrotic syndrome due to NPHS2 mutation.
    Malina M, Cinek O, Janda J, Seeman T.
    Pediatr Nephrol; 2009 Oct 11; 24(10):2051-3. PubMed ID: 19495806
    [Abstract] [Full Text] [Related]

  • 20. Switch from cyclosporine A to mycophenolate mofetil in nephrotic children.
    Ulinski T, Dubourg L, Saïd MH, Parchoux B, Ranchin B, Cochat P.
    Pediatr Nephrol; 2005 Apr 11; 20(4):482-5. PubMed ID: 15719253
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.